# A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

> **NCT03346187** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 60 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Active Comparator(Atorvastatin Calcium Trihydrate+Fenofibrate)
- **DRUG:** Test drug(CKD-337)

## Key facts

- **NCT ID:** NCT03346187
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-19
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-06-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346187, "A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03346187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*